ID: ALA3321929

Max Phase: Preclinical

Molecular Formula: C28H37FN4O5

Molecular Weight: 528.63

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(CNC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)cc1F

Standard InChI:  InChI=1S/C28H37FN4O5/c1-36-23-11-10-20(13-21(23)29)17-31-27(35)22(14-18-7-5-4-6-8-18)32-28(30)33-26(34)16-19-9-12-24(37-2)25(15-19)38-3/h9-13,15,18,22H,4-8,14,16-17H2,1-3H3,(H,31,35)(H3,30,32,33,34)/t22-/m1/s1

Standard InChI Key:  GWVGAFINOCHOOI-JOCHJYFZSA-N

Associated Targets(Human)

Renin 5251 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cathepsin D 3201 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cathepsin D 510 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 528.63Molecular Weight (Monoisotopic): 528.2748AlogP: 3.69#Rotatable Bonds: 11
Polar Surface Area: 121.77Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.52CX Basic pKa: 8.16CX LogP: 3.79CX LogD: 2.97
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.26Np Likeness Score: -0.62

References

1. Grädler U, Czodrowski P, Tsaklakidis C, Klein M, Werkmann D, Lindemann S, Maskos K, Leuthner B..  (2014)  Structure-based optimization of non-peptidic Cathepsin D inhibitors.,  24  (17): [PMID:25086681] [10.1016/j.bmcl.2014.07.054]

Source